Key result
Recombinant VP1 antigen effectively detected IgM in acute and IgG in past enterovirus 71 infections without cross-reacting with coxsackie virus 16 antibodies.
Why the study?
Is recombinant VP1 protein an effective and specific antigen for the serodiagnosis of enterovirus 71 infection?
Is recombinant VP1 protein an effective and specific antigen for the serodiagnosis of enterovirus 71 infection?
Answers are grounded in this paper and cite their sources.
Recombinant VP1 protein is an effective and specific antigen for determining the different phases of enterovirus 71 infection without cross-reactivity to CA16.
To produce enterovirus 71 antigen for diagnostic purposes, the gene encoding the entire capsid protein VP1 was amplified by reverse transcription-polymerase chain reaction (RT-PCR), cloned and expressed in Escherichia coli as a poly-histidine fusion protein. Western blotting experiments with sera from patients with enterovirus 71 infection indicated that immunoglobulin G (IgG) and IgM antibodies bound to a single polypeptide VP1. According to these results, IgM anti-VP1 appeared in sera of patients with a symptomatic enterovirus 71 acute infection, whereas IgG anti-VP1 was present in sera of past infection. This finding suggests that detecting IgG and IgM immune responses against linear epitopes of recombinant VP1 is an effective means of determining the different phases of enterovirus 71 infection. In addition, sera containing coxsackie virus 16 (CA16) antibodies did not cross-react with the recombinant VP1 of enterovirus 71, despite the homology between VP1 proteins of both viruses. Comparison with reference PCR and neutralization assays showed these antibody tests to be appropriate for the serodiagnosis of enterovirus 71 infection.
No takes yet. Share an insight, caveat, or question.
Shih et al. (2000) studied Enterovirus 71 infection. Recombinant VP1 antigen vs. Reference PCR and neutralization assays was evaluated on Detection of IgG and IgM antibodies. Recombinant VP1 antigen effectively detected IgM in acute and IgG in past enterovirus 71 infections without cross-reacting with coxsackie virus 16 antibodies.
Synapse has enriched 10 related papers. Consider them for comparative context: